ArticleCancer management and research2019

Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer.

Muhammad Adeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.